CytomX Therapeutics, Inc.

NASDAQ:CTMX

Biotechnology

Healthcare
$1.88 -0.91%

-$0.03 today

Market cap
$409.85M
Beta
2.09
P/E (TTM)
-8.8
EPS (TTM)
-$0.33
52W Low $1.72High $8.21

Volume 4.39M

Average 4.99M

Price history

CytomX Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-48.63%

Period high

$6.75

Period low

$1.88

Latest

$1.88

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
SC 13G/AOct 28, 2026Oct 28, 2026
4/AOct 16, 2026Oct 16, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 7, 2026Aug 7, 2026
10-QAug 6, 2026Aug 6, 2026
S-8Aug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
3Aug 5, 2026Aug 5, 2026
4Aug 5, 2026Aug 5, 2026
SC 13GAug 3, 2026Aug 3, 2026
3Jul 30, 2026Jul 30, 2026

Competitors

Who does CytomX Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CTMX's filings, answered from its disclosures.

What is the latest CTMX filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does CTMX have?

Intrinsic Alpha currently shows 20 recent filings for CTMX.